Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | NEO2734 |
Synonyms | |
Therapy Description |
NEO 2734 is a dual inhibitor of the BET and CBP/P300 which potentially inhibits tumor growth (Ann Oncol, 29(suppl_8), Oct 2018, abstract 429P, PMID: 32371576). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NEO2734 | NEO 2734|EP31670|EP-31670|NEO-2734|EP36170 | BET Inhibitor (Pan) 32 CBP/p300 inhibitor 13 | NEO 2734 is a dual inhibitor of the BET and CBP/P300 which potentially inhibits tumor growth (Ann Oncol, 29(suppl_8), Oct 2018, abstract 429P, PMID: 32371576). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05488548 | Phase I | NEO2734 | Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors | Recruiting | USA | 0 |